|
|
|
Volumn 20, Issue 4, 2008, Pages 28-
|
|
Abacavir/3TC vs. tenofovir/FTC: interim results from ACTG 5202.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2',3' DIDEOXYNUCLEOSIDE DERIVATIVE;
ABACAVIR;
ADENINE;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
EMTRICITABINE;
LAMIVUDINE;
PHOSPHONIC ACID DERIVATIVE;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
TENOFOVIR;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG COMBINATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MULTICENTER STUDY;
PHASE 3 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
ADENINE;
DEOXYCYTIDINE;
DIDEOXYNUCLEOSIDES;
DRUG THERAPY, COMBINATION;
HIV INFECTIONS;
HUMANS;
LAMIVUDINE;
PHOSPHONIC ACIDS;
REVERSE TRANSCRIPTASE INHIBITORS;
|
|
EID: 63149165917
PISSN: 10431543
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (6)
|
|
References (0)
|
